The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Melphalan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Melphalan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Melphalan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Melphalan in Multiple Myeloma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Melphalan include GlaxoSmithKline, Celon Laboratories, Natco Pharma, Emcure Pharmaceuticals and GLS Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Melphalan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melphalan.
Report Scope
The Melphalan market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melphalan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melphalan companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Celon Laboratories
Natco Pharma
Emcure Pharmaceuticals
GLS Pharma
Segment by Type
2mg Tables
5mg Tables
50mg Injections
Segment by Application
Multiple Myeloma
Ovarian Cancer
AL Amyloidosis
Malignant Melanoma
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melphalan companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Melphalan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Melphalan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Melphalan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Melphalan in Multiple Myeloma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Melphalan include GlaxoSmithKline, Celon Laboratories, Natco Pharma, Emcure Pharmaceuticals and GLS Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Melphalan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melphalan.
Report Scope
The Melphalan market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melphalan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melphalan companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Celon Laboratories
Natco Pharma
Emcure Pharmaceuticals
GLS Pharma
Segment by Type
2mg Tables
5mg Tables
50mg Injections
Segment by Application
Multiple Myeloma
Ovarian Cancer
AL Amyloidosis
Malignant Melanoma
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melphalan companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melphalan Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 2mg Tables
1.2.3 5mg Tables
1.2.4 50mg Injections
1.3 Market by Application
1.3.1 Global Melphalan Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Multiple Myeloma
1.3.3 Ovarian Cancer
1.3.4 AL Amyloidosis
1.3.5 Malignant Melanoma
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Melphalan Market Perspective (2019-2030)
2.2 Melphalan Growth Trends by Region
2.2.1 Global Melphalan Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Melphalan Historic Market Size by Region (2019-2024)
2.2.3 Melphalan Forecasted Market Size by Region (2025-2030)
2.3 Melphalan Market Dynamics
2.3.1 Melphalan Industry Trends
2.3.2 Melphalan Market Drivers
2.3.3 Melphalan Market Challenges
2.3.4 Melphalan Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melphalan Players by Revenue
3.1.1 Global Top Melphalan Players by Revenue (2019-2024)
3.1.2 Global Melphalan Revenue Market Share by Players (2019-2024)
3.2 Global Melphalan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Melphalan Revenue
3.4 Global Melphalan Market Concentration Ratio
3.4.1 Global Melphalan Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melphalan Revenue in 2023
3.5 Melphalan Key Players Head office and Area Served
3.6 Key Players Melphalan Product Solution and Service
3.7 Date of Enter into Melphalan Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melphalan Breakdown Data by Type
4.1 Global Melphalan Historic Market Size by Type (2019-2024)
4.2 Global Melphalan Forecasted Market Size by Type (2025-2030)
5 Melphalan Breakdown Data by Application
5.1 Global Melphalan Historic Market Size by Application (2019-2024)
5.2 Global Melphalan Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Melphalan Market Size (2019-2030)
6.2 North America Melphalan Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Melphalan Market Size by Country (2019-2024)
6.4 North America Melphalan Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Melphalan Market Size (2019-2030)
7.2 Europe Melphalan Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Melphalan Market Size by Country (2019-2024)
7.4 Europe Melphalan Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melphalan Market Size (2019-2030)
8.2 Asia-Pacific Melphalan Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Melphalan Market Size by Region (2019-2024)
8.4 Asia-Pacific Melphalan Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Melphalan Market Size (2019-2030)
9.2 Latin America Melphalan Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Melphalan Market Size by Country (2019-2024)
9.4 Latin America Melphalan Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melphalan Market Size (2019-2030)
10.2 Middle East & Africa Melphalan Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Melphalan Market Size by Country (2019-2024)
10.4 Middle East & Africa Melphalan Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Melphalan Introduction
11.1.4 GlaxoSmithKline Revenue in Melphalan Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Celon Laboratories
11.2.1 Celon Laboratories Company Detail
11.2.2 Celon Laboratories Business Overview
11.2.3 Celon Laboratories Melphalan Introduction
11.2.4 Celon Laboratories Revenue in Melphalan Business (2019-2024)
11.2.5 Celon Laboratories Recent Development
11.3 Natco Pharma
11.3.1 Natco Pharma Company Detail
11.3.2 Natco Pharma Business Overview
11.3.3 Natco Pharma Melphalan Introduction
11.3.4 Natco Pharma Revenue in Melphalan Business (2019-2024)
11.3.5 Natco Pharma Recent Development
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Detail
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Melphalan Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Melphalan Business (2019-2024)
11.4.5 Emcure Pharmaceuticals Recent Development
11.5 GLS Pharma
11.5.1 GLS Pharma Company Detail
11.5.2 GLS Pharma Business Overview
11.5.3 GLS Pharma Melphalan Introduction
11.5.4 GLS Pharma Revenue in Melphalan Business (2019-2024)
11.5.5 GLS Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Melphalan Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 2mg Tables
Table 3. Key Players of 5mg Tables
Table 4. Key Players of 50mg Injections
Table 5. Global Melphalan Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Melphalan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Melphalan Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Melphalan Market Share by Region (2019-2024)
Table 9. Global Melphalan Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Melphalan Market Share by Region (2025-2030)
Table 11. Melphalan Market Trends
Table 12. Melphalan Market Drivers
Table 13. Melphalan Market Challenges
Table 14. Melphalan Market Restraints
Table 15. Global Melphalan Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Melphalan Market Share by Players (2019-2024)
Table 17. Global Top Melphalan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melphalan as of 2023)
Table 18. Ranking of Global Top Melphalan Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Melphalan Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Melphalan Product Solution and Service
Table 22. Date of Enter into Melphalan Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melphalan Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Melphalan Revenue Market Share by Type (2019-2024)
Table 26. Global Melphalan Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Melphalan Revenue Market Share by Type (2025-2030)
Table 28. Global Melphalan Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Melphalan Revenue Market Share by Application (2019-2024)
Table 30. Global Melphalan Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Melphalan Revenue Market Share by Application (2025-2030)
Table 32. North America Melphalan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Melphalan Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Melphalan Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Melphalan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Melphalan Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Melphalan Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Melphalan Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Melphalan Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Melphalan Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Melphalan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Melphalan Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Melphalan Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Melphalan Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Melphalan Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Melphalan Market Size by Country (2025-2030) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Melphalan Product
Table 50. GlaxoSmithKline Revenue in Melphalan Business (2019-2024) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Celon Laboratories Company Detail
Table 53. Celon Laboratories Business Overview
Table 54. Celon Laboratories Melphalan Product
Table 55. Celon Laboratories Revenue in Melphalan Business (2019-2024) & (US$ Million)
Table 56. Celon Laboratories Recent Development
Table 57. Natco Pharma Company Detail
Table 58. Natco Pharma Business Overview
Table 59. Natco Pharma Melphalan Product
Table 60. Natco Pharma Revenue in Melphalan Business (2019-2024) & (US$ Million)
Table 61. Natco Pharma Recent Development
Table 62. Emcure Pharmaceuticals Company Detail
Table 63. Emcure Pharmaceuticals Business Overview
Table 64. Emcure Pharmaceuticals Melphalan Product
Table 65. Emcure Pharmaceuticals Revenue in Melphalan Business (2019-2024) & (US$ Million)
Table 66. Emcure Pharmaceuticals Recent Development
Table 67. GLS Pharma Company Detail
Table 68. GLS Pharma Business Overview
Table 69. GLS Pharma Melphalan Product
Table 70. GLS Pharma Revenue in Melphalan Business (2019-2024) & (US$ Million)
Table 71. GLS Pharma Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melphalan Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Melphalan Market Share by Type: 2023 VS 2030
Figure 3. 2mg Tables Features
Figure 4. 5mg Tables Features
Figure 5. 50mg Injections Features
Figure 6. Global Melphalan Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Melphalan Market Share by Application: 2023 VS 2030
Figure 8. Multiple Myeloma Case Studies
Figure 9. Ovarian Cancer Case Studies
Figure 10. AL Amyloidosis Case Studies
Figure 11. Malignant Melanoma Case Studies
Figure 12. Others Case Studies
Figure 13. Melphalan Report Years Considered
Figure 14. Global Melphalan Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Melphalan Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Melphalan Market Share by Region: 2023 VS 2030
Figure 17. Global Melphalan Market Share by Players in 2023
Figure 18. Global Top Melphalan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melphalan as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Melphalan Revenue in 2023
Figure 20. North America Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Melphalan Market Share by Country (2019-2030)
Figure 22. United States Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Melphalan Market Share by Country (2019-2030)
Figure 26. Germany Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Melphalan Market Share by Region (2019-2030)
Figure 34. China Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Melphalan Market Share by Country (2019-2030)
Figure 42. Mexico Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Melphalan Market Share by Country (2019-2030)
Figure 46. Turkey Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Melphalan Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Melphalan Business (2019-2024)
Figure 49. Celon Laboratories Revenue Growth Rate in Melphalan Business (2019-2024)
Figure 50. Natco Pharma Revenue Growth Rate in Melphalan Business (2019-2024)
Figure 51. Emcure Pharmaceuticals Revenue Growth Rate in Melphalan Business (2019-2024)
Figure 52. GLS Pharma Revenue Growth Rate in Melphalan Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
